New drug combo tested for tough cancers
Disease control
Completed
This early-phase study tested a new drug called AGEN1777, given alone or with another cancer drug (a PD-1 inhibitor), in 25 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check safety and find the right dose. This is a f…
Phase: PHASE1 • Sponsor: Agenus Inc. • Aim: Disease control
Last updated May 14, 2026 12:03 UTC